Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure - Archive ouverte HAL Access content directly
Journal Articles BMC Infectious Diseases Year : 2014

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure

(1, 2) , (1) , (3) , (1) , (1) , (3) , (3) , (4) , (2) , (1)
1
2
3
4

Domains

Life Sciences [q-bio] Human health and pathology Infectious diseases
Fichier principal
Vignette du fichier
1471-2334-14-S2-O1.pdf (52.39 Ko) Télécharger le fichier
Vignette du fichier
1471-2334-14-S2-O1.xml (5.14 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Ed. BMC  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00995731

Submitted on : Friday, May 23, 2014-5:04:08 PM

Last modification on : Friday, October 22, 2021-3:29:12 AM

Long-term archiving on: Monday, August 25, 2014-11:35:49 AM

Download

Dates and versions

inserm-00995731 , version 1 (23-05-2014)

Identifiers

  • HAL Id : inserm-00995731 , version 1

Cite

Sofiane Mohamed, Guillaume Penaranda, Dimitri Gonzalez, Claire Camus, Hacène Khiri, et al.. Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure. BMC Infectious Diseases, 2014, 14 (Suppl 2), pp.O1. ⟨inserm-00995731⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM CNRS UNIV-AMU CRCM
170 View
264 Download

Share

Gmail Facebook Twitter LinkedIn More